Proteomics

Dataset Information

0

Histone PTM profiling analysis of EZH2 mutants in isogenic cells


ABSTRACT: The Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit (EZH2) is an essential epigenetic modifier able to methylate lysine 27 on histone H3 (H3K27) to induce chromatin compaction, protein complex recruitment and ultimately transcriptional repression. Hematologic malignancies, including Diffuse Large B cell lymphoma (DLBCL) and Acute myeloid leukemia (AML) have shown a high EZH2-mutation frequency (>20%) associated with poor clinical outcomes. Particularly, two distinct oncogenic mutations, so-called gain-of-function (Y641F and A677G) and loss-of-function (H689A and F667I) are found in the catalytic domain of EZH2. In this study, a comprehensive multi-omics approach was employed to characterize downstream effects of H3K27me3 deposition driven by EZH2 mutations. Human embryonic kidney cells (HEK293T) were transfected to generate three stable EZH2 mutants: EZH2(Y641F), EZH2(A677G), and EZH2(H689A/F667I), which were validated via immunoblotting and DIA-MS-based histone profiling assay. The histone profiling assay demonstrated a significant increase of approximately two-fold in H3.1/H3.3K27me3 for Y641F EZH2 mutant. There was a modest increase in the combinatorial PTMs H3.1/H3.3K27me3K36me1 and a significant depletion in H3.1 and H3.3 K27me2. The most depleted peptide was H3.3K27me2K36me2. For the A677G EZH2 mutant, the assay demonstrated an enrichment on H3.1/H3.3K27me3, combinatorial K27me3K36me1 and a slight increase in K27me1 and K18ac but only on H3.1. The most depleted peptide was H3.3K27me2K36me2. The H689A/F667I cell line has the most alterations in global histone PTMs. The most highly enriched were H3.1/H3.3K36me2, H3.1K9me3 and H3.3K36me1. The most depleted modifications were H3.1K23ac and H3.1K27me3.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture, Embryonic Stem Cell

DISEASE(S): Acute Leukemia

SUBMITTER: Julian Aldana  

LAB HEAD: Michael A. Freitas

PROVIDER: PXD042953 | Pride | 2023-10-24

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
07092019_A677G_1.raw Raw
07092019_A677G_2.raw Raw
07092019_A677G_3.raw Raw
07092019_A677G_4.raw Raw
07092019_DM_1.raw Raw
Items per page:
1 - 5 of 18
altmetric image

Publications

Integrative Multi-Omics Analysis of Oncogenic EZH2 Mutants: From Epigenetic Reprogramming to Molecular Signatures.

Aldana Julian J   Gardner Miranda L ML   Freitas Michael A MA  

International journal of molecular sciences 20230712 14


Somatic heterozygous mutations in the active site of the enhancer of zeste homolog 2 (EZH2) are prevalent in diffuse large B-cell lymphoma (DLBCL) and acute myeloid leukemia (AML). The methyltransferase activity of EZH2 towards lysine 27 on histone H3 (H3K27) and non-histone proteins is dysregulated by the presence of gain-of-function (GOF) and loss-of-function (LOF) mutations altering chromatin compaction, protein complex recruitment, and transcriptional regulation. In this study, a comprehensi  ...[more]

Similar Datasets

2017-07-28 | PXD005300 | Pride
2019-08-01 | PXD013637 | Pride
2022-10-31 | PXD035578 | Pride
2013-06-15 | E-GEOD-42629 | biostudies-arrayexpress
2024-02-14 | PXD042624 | Pride
2019-11-22 | PXD013766 | Pride
2014-05-02 | E-GEOD-56394 | biostudies-arrayexpress
2012-05-15 | E-GEOD-36626 | biostudies-arrayexpress
2012-05-15 | E-GEOD-36629 | biostudies-arrayexpress
2014-09-20 | E-GEOD-61586 | biostudies-arrayexpress